A Phase I, 3-part Study to Assess the Safety and Tolerability, Pharmacokinetics (including Food Effekt) and Pharmacodynamics of Oral Doses of AZD5672 Following Single and Multiple Doses Administered for up to 28 Days in Healthy Volunteers
Study identifier:D1710C00004
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Phase I, 3-part Study to Assess the Safety and Tolerability, Pharmacokinetics (including Food Effekt) and Pharmacodynamics of Oral Doses of AZD5672 Following Single and Multiple Doses Administered for up to 28 Days in Healthy Volunteers
Medical condition
Rheumatoid Arthritis
Phase
Phase 1
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Sept 2006
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
